/ALCAR.PA

ALCAR.PA Stock - Carmat S.A.

Q: What is the analyst price target for ALCAR.PA?

Analyst price target information is not currently available for ALCAR.PA.

Q: What is ALCAR.PA's market cap?

Market capitalization information is not currently available for ALCAR.PA.

Healthcare|Medical - Devices|PAR

$0.10+0.00%

+$0.00 (+0.00%) • Sep 24

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.11

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ALCAR.PA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.10

52W High$1.51

52W Low$0.09

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$7.00M	$2.85M	$345,000	$2.23M	$9,000
Gross Profit	N/A	$-30,971,000	$-54,148,000	$-52,478,000	$-20,079,000
Gross Margin	0.0%	-1087.5%	-15695.1%	-2354.3%	-223100.0%
Operating Income	$-49,200,000	$-52,519,000	$-52,054,000	$-60,417,000	$-36,411,000
Net Income	$-51,400,000	$-53,869,000	$-53,681,000	$-61,873,000	$-36,963,000
Net Margin	-734.3%	-1891.5%	-15559.7%	-2775.8%	-410700.0%
EPS	$-2.26	$-2.36	$-2.37	$-3.98	$-2.84

Company Overview

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It The company was founded in 2008 and is headquartered in Vélizy-Villacoublay, France.

Visit Website

Earnings History & Surprises

ALCAR.PA

Beat Rate

11%

Last 9 quarters

Avg Surprise

-108.6%

EPS vs Estimate

Beats / Misses

1/8

Last 12 quarters

Latest EPS

$-1.11

Q2 2025

EPS Surprise History

Q4 21

-80.4%

$-1.71vs$-0.95

Q1 22

-140.3%

$-2.28vs$-0.95

Q4 22

-53.4%

$-1.32vs$-0.86

Q2 23

-69.7%

$-1.22vs$-0.72

Q3 23

-17.2%

$-1.17vs$-1.00

Q2 24

-171.0%

$-1.19vs$-0.44

Q3 24

-180.5%

$-1.15vs$-0.41

Q2 25

-269.4%

$-1.11vs$-0.30

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	Apr 27, 2026	—	—	—	—
Q4 2025	Dec 12, 2025	—	—	—	—
Q2 2025	Apr 29, 2025	$-0.30	$-1.11	-269.4%	✗ MISS
Q3 2024	Sep 6, 2024	$-0.41	$-1.15	-180.5%	✗ MISS
Q2 2024	May 1, 2024	$-0.44	$-1.19	-171.0%	✗ MISS
Q3 2023	Sep 26, 2023	$-1.00	$-1.17	-17.2%	✗ MISS
Q2 2023	Apr 21, 2023	$-0.72	$-1.22	-69.7%	✗ MISS
Q4 2022	Dec 27, 2022	$-0.86	$-1.32	-53.4%	✗ MISS
Q1 2022	Feb 16, 2022	$-0.95	$-2.28	-140.3%	✗ MISS
Q4 2021	Nov 16, 2021	$-0.95	$-1.71	-80.4%	✗ MISS
Q1 2021	Feb 10, 2021	—	$-1.24	—	—
Q3 2020	Sep 9, 2020	$-1.73	$-1.65	+4.5%	✓ BEAT
Q1 2020	Feb 12, 2020	—	$-1.48	—	—
Q3 2019	Sep 18, 2019	—	$-2.54	—	—
Q1 2019	Feb 13, 2019	—	$-2.45	—	—
Q3 2018	Sep 28, 2018	—	$-2.06	—	—
Q1 2018	Feb 13, 2018	—	$-1.65	—	—
Q3 2017	Sep 26, 2017	—	$-1.87	—	—
Q1 2017	Feb 14, 2017	—	$-2.41	—	—
Q4 2016	Dec 13, 2016	—	$-1.92	—	—